| Heidee D Villanueva, DO | |
|
1011 Baldwin Park Blvd, Baldwin Park, CA 91706-5806 | |
| (626) 851-1011 | |
| Not Available |
| Full Name | Heidee D Villanueva |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 20 Years |
| Location | 1011 Baldwin Park Blvd, Baldwin Park, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346440922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 20A9467 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Santa Monica - Ucla Med Ctr & Orthopaedic Hospital | Santa monica, CA | Hospital |
| Martin Luther King, Jr. Community Hospital | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vep Mlk Emergency Medical Group Inc | 2860707304 | 20 |
| Capital Hospitalist Medical Group Inc | 8921308636 | 21 |
News Archive
Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
Looking to improve your overall life satisfaction? Try regularly hiking in a forest or otherwise engaging with the natural environment.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
For patients with moderate chronic kidney disease (CKD), higher levels of phosphorus in the blood are associated with increased calcification of the major arteries and heart valves - which may contribute to the increased risk of cardiovascular disease in patients with CKD, reports a study in the Journal of the American Society of Nephrology (JASN).
› Verified 3 days ago
| Entity Name | Regents Of The Univ Of Ca Emer Med |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104889138 PECOS PAC ID: 4284538521 Enrollment ID: O20031119001020 |
News Archive
Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
Looking to improve your overall life satisfaction? Try regularly hiking in a forest or otherwise engaging with the natural environment.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
For patients with moderate chronic kidney disease (CKD), higher levels of phosphorus in the blood are associated with increased calcification of the major arteries and heart valves - which may contribute to the increased risk of cardiovascular disease in patients with CKD, reports a study in the Journal of the American Society of Nephrology (JASN).
› Verified 3 days ago
| Entity Name | Vep Mlk Emergency Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841679289 PECOS PAC ID: 2860707304 Enrollment ID: O20150813009584 |
News Archive
Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
Looking to improve your overall life satisfaction? Try regularly hiking in a forest or otherwise engaging with the natural environment.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
For patients with moderate chronic kidney disease (CKD), higher levels of phosphorus in the blood are associated with increased calcification of the major arteries and heart valves - which may contribute to the increased risk of cardiovascular disease in patients with CKD, reports a study in the Journal of the American Society of Nephrology (JASN).
› Verified 3 days ago
| Entity Name | Capital Hospitalist Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992178222 PECOS PAC ID: 8921308636 Enrollment ID: O20151202002282 |
News Archive
Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
Looking to improve your overall life satisfaction? Try regularly hiking in a forest or otherwise engaging with the natural environment.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
For patients with moderate chronic kidney disease (CKD), higher levels of phosphorus in the blood are associated with increased calcification of the major arteries and heart valves - which may contribute to the increased risk of cardiovascular disease in patients with CKD, reports a study in the Journal of the American Society of Nephrology (JASN).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heidee D Villanueva, DO 1011 Baldwin Park Blvd, Baldwin Park, CA 91706-5806 Ph: (626) 851-1011 | Heidee D Villanueva, DO 1011 Baldwin Park Blvd, Baldwin Park, CA 91706-5806 Ph: (626) 851-1011 |
News Archive
Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
Looking to improve your overall life satisfaction? Try regularly hiking in a forest or otherwise engaging with the natural environment.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
For patients with moderate chronic kidney disease (CKD), higher levels of phosphorus in the blood are associated with increased calcification of the major arteries and heart valves - which may contribute to the increased risk of cardiovascular disease in patients with CKD, reports a study in the Journal of the American Society of Nephrology (JASN).
› Verified 3 days ago
Julian Reed Woods, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Vera Barbette Ramos, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Wil Chew, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Taek C. Lee, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
John Y. Chung, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011 | |
Panchanan Shukla, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-5400 | |
Dr. David Christopher Kim, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 621-851-5828 |